---
layout: minimal-medicine
title: Mogamulizumab
---

# Mogamulizumab
### Generic Name
Mogamulizumab

### Usage
Mogamulizumab is a prescription medication used to treat relapsed or refractory (meaning the disease has come back or hasn't responded to other treatments) mycosis fungoides or Sézary syndrome in adults.  These are types of cutaneous T-cell lymphoma (CTCL), a rare cancer affecting the skin's T cells.  Mogamulizumab is indicated for patients who have already received at least one other systemic therapy (treatment affecting the whole body).  It works by targeting specific cells involved in these cancers.


### Dosage
Mogamulizumab is administered intravenously (IV) over at least 60 minutes.  The typical dosage regimen is:

* **Mycosis Fungoides/Sézary Syndrome:** 1 mg/kg on days 1, 8, 15, and 22 of cycle 1, followed by 1 mg/kg on days 1 and 15 of each subsequent 28-day cycle. Treatment continues until disease progression or unacceptable side effects occur.

**Important Considerations:**

* **Premedication:**  Before the first infusion, and subsequent doses if an infusion reaction occurred during the first, premedication with diphenhydramine and acetaminophen is usually given to help prevent side effects.
* **Dosage Adjustments:** The manufacturer's labeling doesn't provide specific dosage adjustments for mild to moderate hepatic (liver) or renal (kidney) impairment, though studies show no significant pharmacokinetic changes in these cases.  Severe hepatic impairment requires careful consideration by the physician.
* **Pediatric Use:** The safety and effectiveness of Mogamulizumab have not been established in children.


### Side Effects
Mogamulizumab can cause various side effects.  The frequency and severity vary among individuals.  Common side effects (occurring in more than 10% of patients) may include:

* Fatigue
* Headache
* Edema (swelling)
* Diarrhea
* Nausea
* Constipation
* Mucositis (inflammation of the mucous membranes)
* Skin rash
* Skin infection
* Changes in blood sugar levels
* Changes in blood cell counts (including low lymphocyte counts)
* Liver enzyme elevation

Less common, but potentially serious side effects include:

* Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) – severe skin reactions
* Infusion reactions (ranging from mild to life-threatening)
* Infections (including serious and life-threatening infections like sepsis)
* Autoimmune complications
* Hepatitis
* Various organ-related toxicities (e.g., cardiac, pulmonary, renal)


If any adverse effects occur, especially those listed as serious, consult your healthcare provider immediately.

### How it Works
Mogamulizumab is a monoclonal antibody that targets the CC chemokine receptor 4 (CCR4).  CCR4 is a protein found on the surface of certain immune cells, including those involved in mycosis fungoides and Sézary syndrome.  By binding to CCR4, Mogamulizumab triggers antibody-dependent cell-mediated cytotoxicity (ADCC), leading to the destruction of these targeted cancer cells. This helps to reduce the cancer cell population and control the disease.


### Precautions
* **Pregnancy and Breastfeeding:** Mogamulizumab is not recommended during pregnancy or in women of childbearing potential not using effective contraception.  The drug's excretion in breast milk is unknown.  A healthcare professional should weigh the benefits of breastfeeding against potential risks to the child.
* **Drug Interactions:** Mogamulizumab can interact with other medications.  Inform your doctor about all medications, supplements, and herbal remedies you are taking.
* **Autoimmune Disease:**  Patients with a history of autoimmune diseases should be carefully monitored as Mogamulizumab might exacerbate these conditions.
* **Infusion Reactions:**  Infusion reactions can occur; careful monitoring and appropriate premedication are essential.
* **Infections:**  The risk of infections is increased with Mogamulizumab; prompt attention should be given to any signs or symptoms of infection.
* **Hepatitis B:**  Screening for Hepatitis B virus is recommended before starting treatment.


### FAQs
* **Q: How long does it take to see results?** A: The time it takes to see improvement varies among patients. Regular monitoring by your doctor is crucial.
* **Q: How is Mogamulizumab stored?** A: Store Mogamulizumab as directed by your healthcare provider or pharmacist. Usually, it needs to be refrigerated.
* **Q: What should I do if I miss a dose?** A: Contact your healthcare provider immediately to discuss the best course of action.
* **Q: Are there any long-term effects?** A: Long-term effects are still under investigation. Regular checkups are vital to monitor any potential long-term effects.  Your doctor can provide more information.
* **Q: Can I drive or operate machinery while on this medicine?** A: Mogamulizumab can cause fatigue; therefore, avoid driving or operating machinery if you experience fatigue.


**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice.  Always consult your healthcare provider for any health concerns or before making any decisions related to your health or treatment.  The information provided here may not reflect the most recent updates to the drug's prescribing information. Always refer to the official prescribing information for the most current and accurate details.
